| Dr Janki Dhirubhai Amin, MD | |
|
13313 N Meridian Ave Ste D, Oklahoma City, OK 73120-8316 | |
| (405) 755-4290 | |
| (405) 529-5760 |
| Full Name | Dr Janki Dhirubhai Amin |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 11 Years |
| Location | 13313 N Meridian Ave Ste D, Oklahoma City, Oklahoma |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457794430 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RI0200X | Internal Medicine - Infectious Disease | 32071 (Oklahoma) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mercy Home Health | Oklahoma city, OK | Home health agency |
| Mercy Hospital Oklahoma City, Inc | Oklahoma city, OK | Hospital |
| Oklahoma Heart Hospital, Llc | Oklahoma city, OK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mercy Clinic Oklahoma Communities | 1153468921 | 485 |
| Mercy Hospital Tishomingo Inc | 1557542032 | 13 |
News Archive
In a large clinical trial involving more than 700 adults and children researchers showed that the popular herbal remedy Echinacea can cut only half a day from a week long common cold. Echinacea has been marketed for a long time for the common cold. Echinacea, also known as purple coneflower has been shown to have benefits in some earlier studies while some show no benefits.
The death of a child is one of the most painful losses a family can experience, and when it happens unexpectedly it can leave them feeling confused and helpless. To help families cope immediately and long after this tragic event, Becca Peden and Serena Gragert have established the Baby Angels Foundation, a nonprofit organization aimed at raising awareness of Sudden Infant Death Syndrome (SIDS) and funding much-needed resources for bereaved parents in Minnesota and western Wisconsin.
Aduro BioTech, Inc. announced today that the Office of Orphan Products Development of the Food and Drug Administration has granted orphan drug designation for CRS-207, a novel immunotherapy, for the treatment of pancreatic cancer.
Data published today in The Lancet from ABSORB, the world's first clinical trial of a fully bioabsorbable drug eluting stent for the treatment of coronary artery disease, demonstrated no stent thrombosis, no clinically driven target lesion revascularizations (re-treatment of a diseased lesion), and a low (3.3 percent) rate of major adverse cardiac events (MACE) in 30 patients out to one year.
› Verified 4 days ago
| Entity Name | Mercy Clinic Oklahoma Communities |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386874550 PECOS PAC ID: 1153468921 Enrollment ID: O20091027000755 |
News Archive
In a large clinical trial involving more than 700 adults and children researchers showed that the popular herbal remedy Echinacea can cut only half a day from a week long common cold. Echinacea has been marketed for a long time for the common cold. Echinacea, also known as purple coneflower has been shown to have benefits in some earlier studies while some show no benefits.
The death of a child is one of the most painful losses a family can experience, and when it happens unexpectedly it can leave them feeling confused and helpless. To help families cope immediately and long after this tragic event, Becca Peden and Serena Gragert have established the Baby Angels Foundation, a nonprofit organization aimed at raising awareness of Sudden Infant Death Syndrome (SIDS) and funding much-needed resources for bereaved parents in Minnesota and western Wisconsin.
Aduro BioTech, Inc. announced today that the Office of Orphan Products Development of the Food and Drug Administration has granted orphan drug designation for CRS-207, a novel immunotherapy, for the treatment of pancreatic cancer.
Data published today in The Lancet from ABSORB, the world's first clinical trial of a fully bioabsorbable drug eluting stent for the treatment of coronary artery disease, demonstrated no stent thrombosis, no clinically driven target lesion revascularizations (re-treatment of a diseased lesion), and a low (3.3 percent) rate of major adverse cardiac events (MACE) in 30 patients out to one year.
› Verified 4 days ago
| Entity Name | Infectious Disease Associates, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306397658 PECOS PAC ID: 1759661754 Enrollment ID: O20161208002298 |
News Archive
In a large clinical trial involving more than 700 adults and children researchers showed that the popular herbal remedy Echinacea can cut only half a day from a week long common cold. Echinacea has been marketed for a long time for the common cold. Echinacea, also known as purple coneflower has been shown to have benefits in some earlier studies while some show no benefits.
The death of a child is one of the most painful losses a family can experience, and when it happens unexpectedly it can leave them feeling confused and helpless. To help families cope immediately and long after this tragic event, Becca Peden and Serena Gragert have established the Baby Angels Foundation, a nonprofit organization aimed at raising awareness of Sudden Infant Death Syndrome (SIDS) and funding much-needed resources for bereaved parents in Minnesota and western Wisconsin.
Aduro BioTech, Inc. announced today that the Office of Orphan Products Development of the Food and Drug Administration has granted orphan drug designation for CRS-207, a novel immunotherapy, for the treatment of pancreatic cancer.
Data published today in The Lancet from ABSORB, the world's first clinical trial of a fully bioabsorbable drug eluting stent for the treatment of coronary artery disease, demonstrated no stent thrombosis, no clinically driven target lesion revascularizations (re-treatment of a diseased lesion), and a low (3.3 percent) rate of major adverse cardiac events (MACE) in 30 patients out to one year.
› Verified 4 days ago
| Entity Name | Mercy Hospital Tishomingo Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972809002 PECOS PAC ID: 1557542032 Enrollment ID: O20180507002045 |
News Archive
In a large clinical trial involving more than 700 adults and children researchers showed that the popular herbal remedy Echinacea can cut only half a day from a week long common cold. Echinacea has been marketed for a long time for the common cold. Echinacea, also known as purple coneflower has been shown to have benefits in some earlier studies while some show no benefits.
The death of a child is one of the most painful losses a family can experience, and when it happens unexpectedly it can leave them feeling confused and helpless. To help families cope immediately and long after this tragic event, Becca Peden and Serena Gragert have established the Baby Angels Foundation, a nonprofit organization aimed at raising awareness of Sudden Infant Death Syndrome (SIDS) and funding much-needed resources for bereaved parents in Minnesota and western Wisconsin.
Aduro BioTech, Inc. announced today that the Office of Orphan Products Development of the Food and Drug Administration has granted orphan drug designation for CRS-207, a novel immunotherapy, for the treatment of pancreatic cancer.
Data published today in The Lancet from ABSORB, the world's first clinical trial of a fully bioabsorbable drug eluting stent for the treatment of coronary artery disease, demonstrated no stent thrombosis, no clinically driven target lesion revascularizations (re-treatment of a diseased lesion), and a low (3.3 percent) rate of major adverse cardiac events (MACE) in 30 patients out to one year.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Janki Dhirubhai Amin, MD 13313 N Meridian Ave Ste D, Oklahoma City, OK 73120-8316 Ph: (405) 755-4290 | Dr Janki Dhirubhai Amin, MD 13313 N Meridian Ave Ste D, Oklahoma City, OK 73120-8316 Ph: (405) 755-4290 |
News Archive
In a large clinical trial involving more than 700 adults and children researchers showed that the popular herbal remedy Echinacea can cut only half a day from a week long common cold. Echinacea has been marketed for a long time for the common cold. Echinacea, also known as purple coneflower has been shown to have benefits in some earlier studies while some show no benefits.
The death of a child is one of the most painful losses a family can experience, and when it happens unexpectedly it can leave them feeling confused and helpless. To help families cope immediately and long after this tragic event, Becca Peden and Serena Gragert have established the Baby Angels Foundation, a nonprofit organization aimed at raising awareness of Sudden Infant Death Syndrome (SIDS) and funding much-needed resources for bereaved parents in Minnesota and western Wisconsin.
Aduro BioTech, Inc. announced today that the Office of Orphan Products Development of the Food and Drug Administration has granted orphan drug designation for CRS-207, a novel immunotherapy, for the treatment of pancreatic cancer.
Data published today in The Lancet from ABSORB, the world's first clinical trial of a fully bioabsorbable drug eluting stent for the treatment of coronary artery disease, demonstrated no stent thrombosis, no clinically driven target lesion revascularizations (re-treatment of a diseased lesion), and a low (3.3 percent) rate of major adverse cardiac events (MACE) in 30 patients out to one year.
› Verified 4 days ago
Evelyn Lorents, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 920 Sl Young Blvd, Oklahoma City, OK 73104 Phone: 405-271-5963 | |
Patrick Bronson Reeves, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 3366 Nw Expressway Ste 550, Oklahoma City, OK 73112 Phone: 405-942-5442 Fax: 405-942-6448 | |
Dr. Jake Lee Evans, MD Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 800 Stanton L Young Blvd, Aat 6300, Oklahoma City, OK 73104 Phone: 405-271-5963 | |
Metri Haddaden, MD Infectious Disease Medicare: Medicare Enrolled Practice Location: 800 Stanton L Young Blvd # 8425, Oklahoma City, OK 73104 Phone: 405-271-6173 Fax: 410-554-2184 | |
Divya Sharma Divyadarshini, MD Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 800 Stanton L Young Blvd, Oklahoma City, OK 73104 Phone: 405-271-5963 | |
Dr. Philip Barton Miner, Jr., M.D. Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 1000 N Lincoln Blvd, Suite 210, Oklahoma City, OK 73104 Phone: 405-271-4644 Fax: 405-271-3296 | |
Gary Lee Worcester, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 3433 Nw 56th St, Ste 400, Oklahoma City, OK 73112 Phone: 405-947-3341 |